OBJECTIVES: This study examined whether hormonal contraceptive use is associated with diagnosis of bacterial vaginosis (BV) over 1 year. STUDY DESIGN: A total of 3,077 women of reproductive age were recruited from gynecologic and family planning clinics for a 1-year prospective longitudinal study. Data collected over 5 visits included demographics, health and hygiene behaviors, and gynecological exams. Gram stains were used to quantify vaginal flora. RESULTS: There was a decreased risk of overall BV prevalence among oral contraceptive users (odds ratio, OR 0.76; confidence interval, CI 0.63-0.90) and among those using hormonal injection/implant (OR 0.64; CI 0.53-0.76). An increased risk for BV prevalence (OR 1.38; CI 1.11-1.71) and incidence (OR 1.43; 1.02-2.07) was observed among those subjects who had tubal ligation. Greater remission of BV was found among those using hormonal injection or implant (OR 1.67; CI 1.23-2.27) whereas less remission occurred among those subjects who had tubal ligation (OR 0.56; CI 0.39-0.80). CONCLUSIONS: Hormonal contraceptive use is associated with a decreased risk of BV.
OBJECTIVES: This study examined whether hormonal contraceptive use is associated with diagnosis of bacterial vaginosis (BV) over 1 year. STUDY DESIGN: A total of 3,077 women of reproductive age were recruited from gynecologic and family planning clinics for a 1-year prospective longitudinal study. Data collected over 5 visits included demographics, health and hygiene behaviors, and gynecological exams. Gram stains were used to quantify vaginal flora. RESULTS: There was a decreased risk of overall BV prevalence among oral contraceptive users (odds ratio, OR 0.76; confidence interval, CI 0.63-0.90) and among those using hormonal injection/implant (OR 0.64; CI 0.53-0.76). An increased risk for BV prevalence (OR 1.38; CI 1.11-1.71) and incidence (OR 1.43; 1.02-2.07) was observed among those subjects who had tubal ligation. Greater remission of BV was found among those using hormonal injection or implant (OR 1.67; CI 1.23-2.27) whereas less remission occurred among those subjects who had tubal ligation (OR 0.56; CI 0.39-0.80). CONCLUSIONS: Hormonal contraceptive use is associated with a decreased risk of BV.
Authors: Alison C Roxby; David N Fredricks; Katherine Odem-Davis; Kristjana Ásbjörnsdóttir; Linnet Masese; Tina L Fiedler; Stephen De Rosa; Walter Jaoko; James N Kiarie; Julie Overbaugh; R Scott McClelland Journal: J Acquir Immune Defic Syndr Date: 2016-04-01 Impact factor: 3.731
Authors: J Paul Brooks; David J Edwards; Diana L Blithe; Jennifer M Fettweis; Myrna G Serrano; Nihar U Sheth; Jerome F Strauss; Gregory A Buck; Kimberly K Jefferson Journal: Contraception Date: 2016-11-29 Impact factor: 3.375
Authors: Kathryn Peebles; Flavia M Kiweewa; Thesla Palanee-Phillips; Catherine Chappell; Devika Singh; Katherine E Bunge; Logashvari Naidoo; Bonus Makanani; Nitesha Jeenarain; Doerieyah Reynolds; Sharon L Hillier; Elizabeth R Brown; Jared M Baeten; Jennifer E Balkus Journal: Clin Infect Dis Date: 2021-08-02 Impact factor: 9.079
Authors: Athena P Kourtis; Lisa Haddad; Jennifer Tang; Lameck Chinula; Stacey Hurst; Jeffrey Wiener; Sascha Ellington; Julie A E Nelson; Amanda Corbett; Kristina De Paris; Caroline C King; Mina Hosseinipour; Irving F Hoffman; Denise J Jamieson Journal: Contemp Clin Trials Date: 2016-11-09 Impact factor: 2.226
Authors: Tessa Madden; Jaclyn M Grentzer; Gina M Secura; Jenifer E Allsworth; Jeffrey F Peipert Journal: Sex Transm Dis Date: 2012-03 Impact factor: 2.830
Authors: Mark A Klebanoff; William W Andrews; Jun Zhang; Rebecca M Brotman; Tonja R Nansel; Kai-Fun Yu; Jane R Schwebke Journal: Sex Transm Dis Date: 2010-03 Impact factor: 2.830
Authors: R Scott McClelland; Barbra A Richardson; Susan M Graham; Linnet N Masese; Ruth Gitau; Ludo Lavreys; Kishorchandra Mandaliya; Walter Jaoko; Jared M Baeten; Jeckoniah O Ndinya-Achola Journal: Sex Transm Dis Date: 2008-06 Impact factor: 2.830
Authors: Mark A Klebanoff; Tonja R Nansel; Rebecca M Brotman; Jun Zhang; Kai-Fun Yu; Jane R Schwebke; William W Andrews Journal: Sex Transm Dis Date: 2010-02 Impact factor: 2.830
Authors: K Baisley; J Changalucha; H A Weiss; K Mugeye; D Everett; I Hambleton; P Hay; D Ross; C Tanton; T Chirwa; R Hayes; D Watson-Jones Journal: Sex Transm Infect Date: 2009-05-26 Impact factor: 3.519